New knowledge in psoriasis etiopathogenesis; protein p40 blocade

Abstract

Bloking p40 by human monoclonal antibodies ustekinumab and briakinumab seems to be an effective biological therapy of severe plaque psoriasis.

Keywords

• Psoriasis
• biologic therapy
• p40 blokade
• ustekinumab
• briakinumab